And whereas researchers have in the past focused largely on average susceptibility when looking at the distribution of disease among a particular population, CEHS scientists are among those now looking at populations with greater- or lesser-than-average disease susceptibility, Swenberg says.
The genomics revolution has contributed to the fast growth of the CEHS.
Led by CEHS deputy director Marilie Gammon, researchers examined 1,000 blood samples from newly diagnosed breast cancer patients and controls.
Lynn and her staff draw on CEHS research by Gammon, Millikan, and others to dispel that myth.
In fiscal years 2001 and 2002, recipients used $165,000 in CEHS pilot funds to garner a 22-fold return of more than $3.